A microchip that mimics the function of the human brain could one day result in a mobile phone with the memory capacity of a desktop computer, researchers report.

Despite the naysayers, more and more women are gaining success in the business of science. Our global investigation shows what it takes: good education, determination, a good employer, and some luck. Memo to government – Help them out.

This device delivers large molecules directly into cells, and even into specific sites within cells, whilst avoiding the cellular damage associated with other drug delivery methods.

Energy: The Manchester “bobber” is using the power of ocean waves to find a lower-cost route to alternative energy.

Partnerships: An EU project aims to design road-hardened microchips in a fast-changing market.

Imperial College London's technology commercialisation company is betting on a spin-out company, deltaDOT, to speed detection and decrease costs of finding new proteins for drug discovery.

Avidex is teaming up with diabetes specialists at King’s College London to work on a new approach to treating the Type I form of the disease.

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.

Nemerix, a semiconductor company spun out from the Swiss Federal Institute of Technology in Zurich, has closed a €25 million series B financing round.

Oslo-based anticancer company Algeta has closed a series A financing round totaling €23 million.